Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 23 SEPTEMBER 2019

New Anti-Monopoly Regulations In Force In China

Orrick
Explore more from Orrick

September 1, 2019 may be seen as a new starting point for the enforcement of China's antitrust and competition laws.

ChinaGovernment, Public Sector
Shelley Zhang
Shelley Zhang
Till Steinvorth
Till Steinvorth
Author LinkedIn connections

September 1, 2019 may be seen as a new starting point for the enforcement of China's antitrust and competition laws. On this date, three new sets of rules and regulations (the "Three New Regulations") took effect, which were issued by China's newly formed competition authority, the State Administration for Market Regulation ("SAMR"): [1]

  • the Interim Provisions on Prohibiting Monopoly Agreements ("IPP-MA"),
  • the Interim Provisions on Prohibiting Abuse of Dominant Market Positions ("IPP-AD"), and
  • the Interim Provisions on Prohibiting the Acts of Eliminating or Restricting Competition by Abuse of Administrative Power ("IPP-AAP").[2]

The Three New Regulations are expected to provide clear guidance for the SAMR and the provincial market supervision departments in their enforcement of China's Anti-Monopoly Law ("AML").[3]

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

In-Depth Analysis Of State Council Order No. 841: Who Will Be Affected By The New Exit And Entry Administration Rules?

China's new exit and entry regulations introduce significant changes affecting technical personnel, individuals with cross-border assets, public officials, and intermediary service providers. The provisions strengthen authenticity reviews, connect technology export controls with travel restrictions, and establish a comprehensive framework for managing cross-border movement while balancing national security with legitimate international activities.
ChinaGovernment, Public Sector
Han Kun Law Offices
Han Kun Law Offices
Article

Bipartisan Senate Bill Would Prevent “Offshoring Biotech Industry To Communist China”

Senators Pete Ricketts and Elissa Slotkin have introduced bipartisan legislation that would subject American investments in adversary biotechnology to federal review requirements. The Biotech Investment National Security Act would amend the COINS Act to include pharmaceutical and biological product development in the list of sectors requiring Treasury Department screening for outbound investments to countries of concern, particularly China.
ChinaGovernment, Public Sector
Bergeson & Campbell
Bergeson & Campbell
Article

China Links Export Controls To Exit Bans: What State Council Order No. 841 Means For Multinational Companies

China's new immigration regulation introduces a significant provision allowing exit bans on Chinese citizens who violate export control or technology transfer rules that may endanger national, industrial, or technological security. This development creates potential complications for multinational companies operating in technology-intensive industries, as Chinese employees, engineers, researchers, or executives could be barred from departing China without prior notice, affecting cross-border mobility, joint
ChinaGovernment, Public Sector
Greenberg Traurig
Greenberg Traurig